A case of belatacept-induced chilblain lupus

A case of belatacept-induced chilblain lupus

Bibliographic Details
Main Authors:	Neha Kinariwalla, MPhil, Meera Tarazi, MD, Jesse M. Lewin, MD, Sameera Husain, MD, Syed A. Husain, MD, Stephanie M. Gallitano, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	JAAD Case Reports
Subjects:	belatacept chilblains systemic lupus erythematous immunosuppression kidney transplant
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622000261

Similar Items

Chilblain lupus erythematosus in an adolescent girl
by: Shikha Bansal, et al.
Published: (2014-01-01)

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series
by: Nadine Shabeeb, MD, MPH, et al.
Published: (2021-06-01)

Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
by: Hengcheng Zhang, et al.
Published: (2021-02-01)

Belatacept and mediastinal histoplasmosis in a kidney transplant patient
by: Hernán Trimarchi, et al.
Published: (2016-04-01)

Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition
by: Zbigniew Heleniak, et al.
Published: (2022-02-01)

BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01)

Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
by: Yannis Lombardi, et al.
Published: (2022-07-01)

New-onset chilblains in close temporal association to mRNA-1273 vaccination
by: Connie Kha, MD, et al.
Published: (2021-06-01)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
by: Thibault Letellier, et al.
Published: (2022-06-01)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
by: Ibrahim Tawhari, et al.
Published: (2022-12-01)

Belatacept associated - cytomegalovirus retinitis in a kidney transplant recipient: a case report and review of the literature
by: Pierre-Guillaume Deliège, et al.
Published: (2020-12-01)

Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi–Goutie’res syndrome
by: Cuili Yi, et al.
Published: (2020-04-01)

A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents
by: Gabriella Fabbrocini, MD, et al.
Published: (2020-12-01)

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
by: Florian Terrec, et al.
Published: (2021-11-01)

A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation
by: Stéphanie Chhun, et al.
Published: (2023-11-01)

Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation
by: Laure Esposito, et al.
Published: (2024-04-01)

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression
by: Jean L. Koff, et al.
Published: (2024-01-01)

Belatacept as a Treatment Option in Patients with Severe BK Polyomavirus Infection and High Immunological Risk—Walking a Tightrope between Viral Control and Prevention of Rejection
by: Ulrich Jehn, et al.
Published: (2022-05-01)

Invasive bacillary angiomatosis in a kidney transplant recipient: A challenging case on belatacept immunosuppression
by: Rita Eid, et al.
Published: (2023-08-01)

Chilblain-like Lesions after COVID-19 Vaccination: A Case Series
by: Roberto Russo, et al.
Published: (2022-05-01)

Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future
by: William H. Kitchens, et al.
Published: (2023-12-01)

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
by: Mira Choi, et al.
Published: (2020-08-01)

Biomarkers in biological fluids and their potential use as indicators of lupus nephritis in individuals with systemic lupus erythematous
by: Lisandro Pacheco-Lugo, et al.
Published: (2014-05-01)

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series
by: Christophe Masset, et al.
Published: (2024-04-01)

New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis
by: Cara Barber, MD, MPH, et al.
Published: (2022-07-01)

A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients
by: Anne Eugster, et al.
Published: (2022-07-01)

Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients
by: Anne Eugster, et al.
Published: (2022-11-01)

Lupus profundus and discoid lupus following a diagnosis of Kikuchi-Fujimoto disease
by: JaBreia F. James, BS, et al.
Published: (2023-03-01)

Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
by: Dominique Bertrand, et al.
Published: (2020-10-01)

Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art
by: Andrea Bassi, et al.
Published: (2021-01-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialPlain-Language Summary
by: Obbo W. Bredewold, MD, et al.
Published: (2023-01-01)

CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01)

Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab
by: Vasudha V Sardesai, et al.
Published: (2015-01-01)

Coronavirus disease-19 triggered systemic lupus erythematous: A novel entity
by: Yadvir Garg, et al.
Published: (2023-01-01)

Management of Depression in Children With Lupus Erythematosus System
by: Risza Subiantoro, et al.
Published: (2021-09-01)

Pseudo-Chilblains in a COVID-19 Patient
by: Ricardo Moutinho-Guilherme, et al.
Published: (2021-04-01)

Pseudo-Chilblains in a COVID-19 Patient
by: Ricardo Moutinho-Guilherme, et al.
Published: (2021-06-01)

Pseudo-Chilblains in a COVID-19 Patient
by: Ricardo Moutinho-Guilherme, et al.
Published: (2021-04-01)

Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic
by: Roland Aschoff, et al.
Published: (2020-12-01)